Related content

The effect of PTH(1–84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial

By Quesada-Gómez J.   Muschitz C.   Gómez-Reino J.   Greisen H.   Andersen H.   Dimai H.  

Osteoporosis International, Vol. 22, Iss. 9, 2011-09 ,pp. : 2529-2537

Springer Publishing Company

Access to resources Recommend Favorite

Comparing and contrasting the effects of strontium ranelate and other osteoporosis drugs on microarchitecture

By Ferrari S.  

Osteoporosis International, Vol. 21, Iss. 2, 2010-06 ,pp. : 437-442

Springer Publishing Company

Access to resources Recommend Favorite

Strontium ranelate does not stimulate bone formation in ovariectomized rats

By Fuchs R.   Allen M.   Condon K.   Reinwald S.   Miller L.   McClenathan D.   Keck B.   Phipps R.   Burr D.  

Osteoporosis International, Vol. 19, Iss. 9, 2008-09 ,pp. : 1331-1341

Springer Publishing Company

Access to resources Recommend Favorite

Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

By Marquis P.   Roux C.   de la Loge C.   Diaz-Curiel M.   Cormier C.   Isaia G.   Badurski J.   Wark J.   Meunier P.  

Osteoporosis International, Vol. 19, Iss. 4, 2008-04 ,pp. : 503-510

Springer Publishing Company

Access to resources Recommend Favorite

Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis

By Lee H.   Lie D.   Lim K.   Thirumoorthy T.   Pang S.  

Osteoporosis International, Vol. 20, Iss. 1, 2009-01 ,pp. : 161-162

Springer Publishing Company

Access to resources Recommend Favorite